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Abstract Previous studies identified lysine- and tryptophan-
rich sequences within various cationic antimicrobial pep-
tides. In the present study, we synthesized a series of
peptides composed of lysine (K)-tryptophan (W) repeats
(KW)n (where n equals 2, 3, 4 or 5) with amidation of the
C-terminal to increase cationicity. We found that increases
in chain length up to (KW)4 enhanced the peptides’ anti-
bacterial activity; (KW)5 exhibited somewhat less bacteri-
cidal activity than (KW)4. Cytotoxicity, measured as lysis
of human red blood cells, also increased with increasing
chain length. With (KW)5, reduced antibacterial activity
and increased cytotoxicity correlated with greater hydro-
phobicity and self-aggregation in the aqueous environment.
The peptides acted by inducing rapid collapse of the bac-
terial transmembrane potential and induction of membrane
permeability. The mode of interaction of the peptides and
the phosphate groups of lipopolysaccharide was dependent
upon the peptides’ ability to permeate the membrane.
Longer peptides [(KW)4 and (KW)5] but not shorter pep-
tides [(KW)2 and (KW)3] strongly bound and par-
tially inserted into negatively charged, anionic lipid
bilayers. These longer peptides also induced membrane
permeabilization and aggregation of lipid vesicles. The
peptides had a disordered structure in aqueous solution, and
only (KW)4 and (KW)5 displayed a folded conformation on
lipid membranes. Moreover, (KW)4 destroyed and agglu-
tinated bacterial cells, demonstrating its potential as an
antimicrobial agent. Collectively, the results show (KW)4
to be the most efficacious peptide in the (KW)n
series, exhibiting strong antibacterial activity with little
cytotoxicity.
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Introduction
Antimicrobial peptides (AMPs) are small proteins (*40
amino acids residues) (Brown and Hancock 2006) that can
be used as potent weapons against infectious microbes,
including multidrug-resistant bacteria (Hancock 2001).
Indeed, AMPs constitute key parts of the innate immune
systems of numerous organisms, including amphibians, and
mammals. Because conventional antibiotics have specific
intracellular targets, bacteria are able to develop compen-
satory mechanisms that render them resistant (Alanis 2005;
Tenover 2006). In contrast, AMPs bind to the bacterial cell
membrane and perturb its structure. This modus operandi
makes AMPs impervious to bacterial resistance, since
developing resistance would require microbes to alter their
entire membrane lipid composition. Consequently, AMPs
are attractive therapeutic candidates for protection against
multidrug-resistant microbes (Fjell et al. 2011; Brogden
and Brogden 2011; Giuliani and Rinaldi 2011).
AMPs adopt both a-helical and b-sheet secondary
structures within hydrophobic environments (Powers and
Hancock 2003). Despite differences in their secondary
structures, most antimicrobial peptides share certain fea-
tures, including cationicity, hydrophobicity and amphi-
pathicity, which are essential for disruption of bacterial
membranes. The cationicity of AMPs is attributable to the
presence of numerous Arg and Lys residues, while
amphipathicity reflects the presence of polar amino acids
and non-polar, hydrophobic residues on opposite sides of
the peptide secondary structure (Epand et al. 2003; Gopal
et al. 2009; Kiyota et al. 1996; Song et al. 2005). The initial
interaction between the bacterial membrane and an AMP is
electrostatic in nature, since the bacterial membrane con-
sists of anionic lipids such as phosphatidylglycerol and
cardiolipin as well as the zwitterionic lipid phosphatidyl-
ethanolamine (Zilberstein et al. 1979; Lugtenberg and Van
Alphen 1983). Once the polar side of the AMP, which is
enriched with charged residues, binds to the anionic bac-
terial membrane, the hydrophobic region of the peptide
attaches to the hydrophobic core of the lipid bilayer,
thereby causing a partition.
Although charge and amphipathicity greatly influence
the activity of AMPs, naturally occuring AMPs also differ
greatly in length, making it very difficult to correlate chain
length and antimicrobial activity. Because knowing the
optimal length of AMPs could facilitate de novo design of
AMPs (Deslouches et al. 2005), we designed and synthe-
sized a series of peptides of different length, and then
determined their modes of action using lipid bilayer and
bacterial membrane models. We found that the length of
the peptide chain greatly influences target selection, per-




Rink amide 4-methylbenzhydrylamine resin, fluoren-9-
ylmethoxycarbonyl (Fmoc) amino acids and other reagents
for peptide synthesis were purchased from Calbiochem-
Novabiochem (La Jolla, CA, USA). Acrylamide was from
Sigma-Aldrich (St. Louis, MO, USA). Cholesterol (CH,
from porcine liver), L-a-phosphatidylethanolamine (PE,
from E. coli), egg yolk L-a-phosphatidylcholine (PC) and
L-a-phosphatidylglycerol (PG, from E. coli) were from
Avanti Polar Lipids Co. (Alabaster, AL, USA). Calcein,
5-carboxytetramethylrhodamine (TAMRA), 3,30-diethyl-
thiodicarbocyanine iodide (DiSC3-5) and SYTOX Green
were from Molecular Probes (Eugene, OR, USA). All other
reagents were of analytical grade. Buffers were prepared
using double distilled water (Millipore Co.).
Bacterial strains
Escherichia coli (KCTC 1682), Salmonella typhimurium
(KCTC 1926), Pseudomonas aeruginosa (KCTC 1637),
Staphylococcus aureus (KCTC 1621), Bacillus subtilis
(KCTC 1918), and Listeria monocytogenes (KCTC 3710)
were obtained from the Korean Collection for Type Cul-
tures (KCTC). Drug-resistant E. coli strains (CCARM 1229
and CCARM 1238), S. typhimurium strains (CCARM
8007, CCARM 8009, and CCARM 8013), and S. aureus
strains (CCARM 3089, CCARM 3090, CCARM 3108,
CCARM 3114, and CCARM 3126) were from the Culture
Collection of Antibiotic-Resistant Microbes (CCARM) at
Seoul Women’s University, Korea.
Peptide synthesis and purification
The peptides KWKW-NH2 [(KW)2], KWKWKW-NH2
[(KW)3], KWKWKWKW-NH2 [(KW)4], and KWKWKWK
WKW-NH2 [(KW)5] were synthesized using the solid-phase
method with Fmoc chemistry on a solid support of rink
amide 4-methylbenzhydrydrylamine resin. Thereafter, 0.1 M
N-hydroxy benzotriazole (HOBt), 0.45 M 2-(1H-benzo-
triazole-1-yil)-1,1,3,3-tetramethyluroniumhexafluoropho-
sphate (HBTU) in dimethylformamide (DMF) and 2 M N,
N-diisopropyl ethylamine (DIEA) in N-methylpyrrolidone
(NMP) were used as coupling reagents, and a tenfold excess
of Fmoc-amino acid was added during every coupling cycle.
After a final deprotection step using a solution of 20 %
piperidine in DMF, cleavage was carried out using a mixture
of TFA/water/triisopropylsilane (90:5:5) for 2 h at room
temperature. The crude peptides were repeatedly extracted
with diethyl ether and then purified using reverse phase
preparative HPLC on a Vydac C18 column (4.6 9 250 mm,
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300 A˚, 5 lm). The molecular masses of the peptides were
confirmed using a matrix-assisted laser desorption ionization
mass spectrometer (MALDI II, Kratos Analytical Ins.).
Antibacterial activity
The antibacterial activities of the peptides against Gram-
negative, Gram-positive and antibiotic-resistant bacterial
strains were evaluated using the microbroth dilution
method (Park et al. 2003). Aliquots of culture medium
containing bacterial suspensions in mid-logarithmic phase
at a concentration of 2 9 105 colony forming units
(CFU)/ml were added to each well of a multiwell plate
containing peptide solution serially diluted 29 in 10 mM
sodium phosphate buffer (pH 7.2) or phosphate-buffered
saline (PBS, 1.5 mM KH2PO4, 2.7 mM KCl, 8.1 mM
Na2HPO4, 150 mM NaCl, pH 7.2). Growth inhibition was
evaluated by measuring the absorbance at 620 nm using a
Versa-Max microplate Elisa Reader (Molecular Devices
Co., Sunnyvale, CA, USA) after 24 h of incubation at
37 C. The minimum inhibitory concentration (MIC) was
defined as the minimal peptide concentration that com-
pletely inhibited bacterial growth. All MIC measurements
were the average of 3–4 independent experiments.
Human red blood cell (hRBC) hemolysis
Hemolytic activities of the peptides were assessed using
heparinized hRBCs collected from healthy donors. Fresh
hRBCs were washed three times by centrifugation at
8009g for 10 min in PBS (pH 7.2) and then resuspended in
PBS. The peptides were then dissolved in PBS and added
to 100 ll of stock hRBCs suspended in PBS (final RBC
concentration, 4 % v/v), after which the samples were
incubated with gentle agitation for 60 min at 37 C before
centrifugation for 10 min at 8009g. Absorbance of the
supernatants was recorded at 414 nm. In addition, control
samples for zero hemolysis and 100 % hemolysis were
incubated with PBS (Ablank) or 0.1 % Triton X-100 (Atriton),
respectively. Melittin was used as a reference hemolytic
peptide. Percent hemolysis was calculated according to the
following equation:
%Hemolysis ¼ ½ðAsample  AblankÞ=ðAtriton  AblankÞ  100:
Each measurement was conducted in triplicate (Kim et al.
2011).
Computational modeling
The structures of the peptide models were built using
ChemOffice Desktop 2004 for Windows (CambridgeSoft
(CS) Corporation, MA, USA). The structures of linear
peptides were generated and the energies minimized using
Chem3D and the molecular mechanics method (MM2)
(Burkert and Allinger 1982). The sequences of the peptides
were initially added using standard ChemDraw Ultra, after
which the N-and C-termini of the peptide groups were
charged by changing the balances. Amidation of the
C-terminus of each peptide was carried out using Chem3D.
Energy minimizations were run for all of the peptides using
the Chem3D and MM2 methods. Finally, optimized pep-
tides were imported into the Pymol program for visuali-
zation and figure generation (DeLano 2002).
Aggregation states of peptides in aqueous solution
We compared the aggregation states of peptides in water
and PBS by examining Trp fluorescence as a function of
peptide concentration from 1 to 18 lM. Changes in
emission were recorded using a spectrofluorometer
(Perkin-Elmer LS55, Mid Glamorgan, UK) at an excitation
wavelength of 280 nm and an emission wavelength of
300–400 nm.
CD spectroscopy was used to determine the aggregation
states of the peptides in PBS at various concentrations
ranging from 25 to 150 lM. The CD spectra were recorded
between 190 and 250 nm on a Jasco 810 spectropolarim-
eter (Jasco, Tokyo, Japan) equipped with a temperature
control unit. The recordings were made using a quartz cell
with a 0.1-cm path length at 25 C. At least four scans over
the 190–250 nm wavelength range were conducted.
Confocal laser-scanning microscopy (CLSM)
Fluorescently labeled (KW)4 peptide was used for the
CLSM study. Fluorescent labeling of the N-termini of the
peptides was accomplished using TAMRA in DMF
(3–4 eq.) containing 5 % (v/v) DIEA (Ghosh et al. 1997).
Escherichia coli CCARM 1229 or S. aureus CCARM
3090 cells in mid-logarithmic phase were harvested by
centrifugation, washed and re-suspended in PBS (pH 7.2)
to a concentration of 2 9 105 CFU/ml. TAMRA-labeled
peptide was then added to 100 ll of the cell suspension to a
concentration of 12.5 lM, after which the cells were
incubated at 37 C for 10 min, pelleted by centrifugation at
3,0009g for 5 min, and washed three times with PBS. The
action site of TAMRA-labeled (KW)4 was then examined
using an inverted LSM510 laser-scanning microscope (Carl
Zeiss, Go¨ttingen, Germany).
Dansyl polymyxin B (PMB) displacement assay
The binding affinity of each peptide for lipopolysaccharide
(LPS) was determined using dansyl PMB displacement
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assays (Moore et al. 1986). Dansyl PMB (4 lM/ml) and
P. aeruginosa LPS (9 lg/ml) were mixed in 1 ml of 5 mM
HEPES (pH 7.2) for optimal fluorescence. Reductions in
fluorescence were used to calculate the percent displace-
ment of dansyl PMB after peptide treatment. Buffer blank
was subtracted from the peptide spectra. Spectra were
recorded on a Perkin-Elmer LS-50B spectrofluorimeter
using a cuvette with of 1-cm path length. The excitation and
emission wavelengths were 340 and 485 nm, respectively.
Membrane depolarization
Peptide-induced membrane depolarization was examined
using Gram-positive and Gram-negative bacteria as descri-
bed previously (Papo et al. 2002; Sal-Man et al. 2002).
Briefly, E. coli CCARM 1229 and S. aureus CCARM 3090
were grown to mid-logarithmic phase at 37 C with gentle
agitation. The cells were then washed twice in buffer
(20 mM glucose, 5 mM HEPES, PH 7.3) and re-suspended
to an OD600 of 0.05 in similar buffer containing 0.1 M KCl.
The bacterial cells were then incubated with 1 lM DiSC3-5
until the fluorescence reached a stable baseline. After addi-
tion of the indicated concentrations of peptide, changes in
fluorescence were measured using an excitation wavelength
of 622 nm and emission wavelength of 670 nm. The fluo-
rescence of 0.1 % Triton X-100-treated cells served as a
positive control for maximum depolarization.
SYTOX Green uptake
Cultured cells (E. coli CCARM 1229 and S. aureus CCARM
3090) were re-suspended (2 9 107 CFU/ml) in PBS and
incubated with 1 lM SYTOX Green for 10 min in the dark.
Peptides (12.5 lM) were then added to the cell suspension,
and the fluorescence was monitored for 60 min at an excitation
wavelength of 485 nm and emission wavelength of 520 nm.
Kinetic studies
The kinetics of the bactericidal activity of peptides were
evaluated using E. coli CCARM 1229 and S. aureus
CCARM 3090. Mid-logarithmic growth phase bacteria
(2 9 105 CFU/ml) were incubated with peptides at 19 or
29 the MIC at 37 C. Aliquots were removed at the indi-
cated times, appropriately diluted, and plated on LB agar
plates. CFUs were counted after 16 h of incubation at
37 C. All measurements were carried out in triplicate.
Preparation of small and large unilamellar vesicles
(SUVs and LUVs)
SUVs were prepared by sonication of the required amount
of PE:PG (7:3, w/w) or PC:CH (10:1, w/w). Dry lipids
were dissolved in chloroform in a glass vessel, after which
the solvent was removed using a stream of nitrogen gas.
Any remaining trace amounts of organic solvent were then
completely removed by lyophilization overnight, and the
remaining dry lipid film was resuspended in PBS at (pH
7.2) with gentle vortex mixing. The lipid suspensions were
then sonicated at 40 C until clear using a bath-type ultr-
asonicator and extruded 14 times using an Avanti Mini-
Extruder (Avanti Polar Lipids Inc., Alabaster, AL, USA)
with 0.05 lm polycarbonate filters.
LUVs were prepared using the freeze–thaw method
(Mayer et al. 1986). Briefly, dry lipid films were resus-
pended in 1–2 ml of appropriate buffer by vortexing. LUVs
were prepared through nine freeze–thaw cycles in liquid
nitrogen, followed by incubation in a water bath at 50 C.
The suspensions were then extruded 14 times through
0.2-lm polycarbonate membranes, and lipid concentrations
were determined using standard phosphate assays (Stewart
1980).
Calcein leakage from liposomes
PE:PG (7:3, w/w) and PC:CH (10:1, w/w) LUVs with
entrapped calcein were prepared by vortexing the dried
lipids in a dye buffer solution (70 mM calcein, PBS, pH
7.4). The resultant suspension was then subjected to nine
cycles of freeze–thaw in liquid nitrogen, followed by
separation of the calcein-containing vesicles from free
calcein using gel filtration chromatography on a Sephadex
G-50 column. LUVs with entrapped calcein in a suspension
containing 2.5 lM lipid were then incubated for 25 min
with various concentrations of peptide (0.03–0.25 l). The
release of fluorescent calcein was assessed using a spec-
trofluorometer at an excitation wavelength of 480 nm and
an emission wavelength of 520 nm. Complete (100 %)
release was induced by addition of 0.1 % Triton X-100;
spontaneous leakage was negligible. All experiments were
conducted at 25 C, and the apparent percentage of
released calcein was calculated using the following equa-
tion (Matsuzaki et al. 1999):
Release (%) = 100 9 (F - Fo)/(Ft - Fo)
where F and Ft are the fluorescence intensity before and
after the addition of detergent, respectively, and Fo is the
fluorescence of intact vesicles.
Liposome aggregation
The aggregation of lipid vesicles was monitored through
visible absorbance measurements. Peptides (5, 10, 20, and
40 lM) in PBS (pH 7.2) were added to a suspension of
400 lM PE:PG LUVs (7:3, w/w). Absorbance was mea-
sured at 405 nm using a microplate Autoreader before and
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after the addition of the peptides (Oren et al. 1999).
Increased absorbance indicated liposomal aggregation.
Trp fluorescence and acrylamide quenching assays
The fluorescence emission spectrum of Trp within the
peptides was monitored using a spectrofluorometer in the
presence of PE:PG (7:3, w/w) or PC:CH (10:1, w/w) SUVs,
which were used to minimize differential light scattering
effects (Mao and Wallace 1984). Each peptide was added
to 1 ml of 200 lM liposomes, after which the peptides and
liposomes (molar ratio 1:100) were allowed to interact for
10 min at 25 C. The fluorescence was then measured at an
excitation wavelength of 280 nm and an emission wave-
length from 300 to 400 nm.
Fluorescence quenching experiments were conducted
using acrylamide as the quencher. The concentration of
acrylamide in the cuvette ranged from 0.04 to 0.20 M. The
effect of acrylamide on the fluorescence of each peptide
was analyzed using the Stern–Volmer equation
F0/F = 1 ? KSV (Q)
where F0 and F are the fluorescence intensities in the
presence or absence of acrylamide, respectively, KSV is the
Stern–Volmer quenching constant and (Q) is the concen-
tration of acrylamide.
CD spectroscopy
The CD spectra for 50 lM peptide dissolved in PBS alone
(pH 7.2), PBS containing 1 mM PE:PG (7:3, w/w) vesicles,
or PBS containing 1 mM PC:CH (10:1, w/w) vesicles were
scanned in the presence or absence of LPS (0.1 %) dis-
solved in PBS. The CD data represent the average values of
three separate recordings with four scans per sample.
Scanning electron microscopy (SEM)
Mid-logarithmic phase cultured E. coli CCARM 1229 cells
were re-suspended at 2 9 107 CFU/ml in PBS (pH 7.2)
and incubated with 12.5 lM (KW)4 for 1 h at 37 C. The
bacteria were then pelleted by centrifugation at 30009g for
5 min and washed twice in PBS. After removing the
supernatants, the pellets were fixed for 3 h at 4 C in
500 ll of 5 % (v/v) glutaraldehyde in 0.2 M sodium-cac-
odylate buffer (pH 7.4). The samples were then extensively
washed with 0.1 M sodium-cacodylate buffer and treated
with 1 % (w/v) osmium tetroxide in 0.1 M sodium-
cacodylate buffer for 1 h at 4 C in the dark. Thereafter,
the bacteria were washed twice with 5 % (w/v) sucrose in
the same buffer, and dehydrated in a sequential 20, 40, 60,
80, 95 and 100 % ethanol series. After lyophilization and
coating, the samples were examined in a scanning electron
microscope (Hitachi S-2400N, Japan).
Bacterial agglutination assay
Overnight cultures of E. coli CCARM 1229, S. aureus
CCARM 3090 and P. aeruginosa were washed with
10 mM sodium phosphate (pH 7.4) containing 10 % TSB
media. After adjusting the concentration to 2 9 108
CFU/ml, 100 ll aliquots of the bacterial suspension were
incubated with 100 ll of peptide solution (6.25–50 lM) in
a polystyrene plate for 1 h at 37 C. The bacteria were then
stained for 10 min with 1 % (w/v) crystal violet. After the
supernatants containing non-aggregated cells were care-
fully removed, each well was photographed using an
Olympus Inverted Microscope (Olympus 1X71, Tokyo,
Japan) equipped with digital camera (Olympus DP71).
Results
Effects of hydrophobicity and length on the
antibacterial and hemolytic activities of (K–W)n
peptides and computer modeling of peptide structures
The observed molecular weights of the synthetic (KW)n
peptides were well matched to the calculated values. To
determine the antibacterial and hemolytic activities of the
peptides, we used RP-HPLC to assess the level of hydro-
phobicity of the synthetic peptides (Table 1). We found
that the retention times, and thus the relative hydropho-
bicity, of the (KW)n peptides were in the order
(KW)2 \ (KW)3 \ (KW)4 \ (KW)5, indicating that the
hydrophobicity of the synthetic peptides increased with the
addition of KW motifs.
The antibacterial activities of the peptides in PBS and
low ionic strength buffer [sodium phosphate (SP) buffer]
are summarized in Table 1. In general, the antibacterial
activity of the peptides increased with increasing chain
length up to (KW)4. Whereas (KW)2 was inactive against
all strains, (KW)3 and (KW)4 exhibited activity against
S. typhimurium, P. aeruginosa and L. monocytogenes.
Moreover, (KW)4 exhibited stronger antibacterial activity
than the other peptides against all bacterial strains. Inter-
estingly, the antibacterial activity of (KW)5 was similar to
or somewhat weaker than that of (KW)4, indicating that,
with (KW)5, increasing chain length did not lead to an
increase in antibacterial activity.
Neither (KW)2 nor (KW)3 induced hemolysis at a con-
centration of 200 lM (Table 1). In contrast, (KW)4 and
(KW)5 caused 8 and 71 % hemolysis, respectively. The
greater hemolytic activity of (KW)5 likely reflects its
greater hydrophobicity. In addition, Feder et al. (2000)
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reported a linear correlation between hemolysis and the
aggregation state. We therefore next examined the aggre-
gation state of (KW)5 in aqueous solution. Computer
modeling revealed that the clustering of KW motifs within
(KW)n peptides, resulted in different spatial arrangements
and surface areas (Fig. 1).
Table 1 MICs of peptides used against bacterial strains
Microorganisms (KW)2 (KW)3 (KW)4 (KW)5 Melittin Ampicillin Oxacillin
MIC (lM)
Gram (-) bacteria
E. coli [200 ([200) 50 (200) 6.25 (12.5) 50 (12.5) 1.56 (1.56) 50 –
S. typhimurium 50 (200) 3.12 (6.25) 1.56 (1.56) 6.25 (3.12) 0.39 (0.39) 25 –
P. aeruginosa [200 ([200) 12.5 (25) 3.12 (3.12) 25 (6.25) 3.12 (3.12) – –
Gram (?) bacteria
S. aureus [200 ([200) 50 (200) 6.25 (12.5) 25 (12.5) 1.56 (1.56) – 12.5
B. subtilis [200 ([200) 100 (200) 6.25 (12.5) 12.5 (12.5) 1.56 (3.12) – –
L. monocytogenes 200 ([200) 12.5 (25) 3.12 (3.12) 3.12 (3.12) 1.56 (1.56) – –
Resistant strains
E. coli CCARM 1229a [200 ([200) 25 (100) 6.25 (12.5) 50 (12.5) 3.12 (3.12) [200 ([200) –
E. coli CCARM 1238a [200 ([200) 50 (200) 12.5 (12.5) 50 (12.5) 1.56 (1.56) [200 ([200) –
S. typhimurium CCARM 8007b [200 ([200) 50 (200) 12.5 (12.5) 25 (12.5) 6.25 (12.5) [200 ([200) –
S. typhimurium CCARM 8009b [200 ([200) 50 (200) 6.25 (12.5) 25 (12.5) 6.25 (12.5) [200 ([200) –
S. typhimurium CCARM 8013b [200 ([200) 50 (200) 6.25 (12.5) 25 (12.5) 3.12 (6.25) [200 ([200) –
S. aureus CCARM 3089c [200 ([200) 50 (200) 12.5 (12.5) 50 (12.5) 1.56 (1.56) – [200 ([200)
S. aureus CCARM 3090c [200 ([200) 50 (200) 12.5 (12.5) 25 (12.5) 3.12 (3.12) – [200 ([200)
S. aureus CCARM 3108c [200 ([200) 50 (200) 12.5 (12.5) 50 (12.5) 1.56 (1.56) – [200 ([200)
S. aureus CCARM 3114c [200 ([200) 50 (200) 12.5 (12.5) 25 (12.5) 3.12 (3.12) – [200 ([200)
S. aureus CCARM 3126c [200 ([200) 50 (200) 12.5 (12.5) 25 (12.5) 1.56 (1.56) – [200 ([200)
Hemolysisd (%) 0 0 8 71 100 – –
GMe (lM) 387.5 159.7 10.6 10.9 3.6 – –
MHCf (lM) 550 350 210 50 0.5 – –
Therapeutic indexg 1.4 2.1 19.8h 4.5 0.1 – –
Retention timei 17.6 19.5 21.7 23.8 – – –
Relative hydrophobicityj (cationicity)k 28 (?3)g 31 (?4)g 34 (?5)g 38 (?6)g – – –
Calculatedl 645.7 960.1 1274.6 1588.9 – – –
Observedl 646.6 960.5 1274.9 1589.6 – – –
Antibacterial assays were performed in 10 mM sodium phosphate buffer, pH 7.2 and PBS, pH 7.2 (number in parentheses)
a Drug-resistant Escherichia coli strains
b Drug-resistant Salmonella typhimurium strains
c Drug-resistant Staphylococcus aureus strains
d Percent hemolysis with 200 lM peptide in PBS
e GM denotes the geometric mean of MIC values (in PBS) from all 16 microbial strains in this table. When no detectable antimicrobial activity
was observed at 200 lM, a value of 400 lM was used for calculation of the therapeutic index
f The minimal peptide concentration [minimal hemolytic concentration (MHC)] that produces 10 % hemolysis
g Therapeutic index = MHC/GM. Larger values indicate greater antimicrobial specificity
h The boldface entries show the best peptide with broad-spectrum activity in terms of the therapeutic index against both Gram-negative and
Gram-positive bacteria
i Retention time was measured using a C18 reverse phase analytical column (4.6 9 250 mm, 300 A˚, 5 nm). The peptides were eluted over
60 min using a linear gradient of 5–60 % acetonitrile in water containing 0.05 % (v/v) trifluoroacetic acid
j Relative hydrophobicity is reflected by the percent of acetonitrile at the retention time (Rosenfeld et al. 2010)
k Cationicity (number in parentheses)
l Molecular weights of (KW)n peptides
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Structure and organization of (KW)n peptides
in aqueous solution
To investigate why (KW)5 exhibited less antibacterial
activity and greater hemolytic activity than (KW)4, we
assessed the self-aggregation of (KW)4 and (KW)5 in water
and PBS. As determined from the Trp fluorescence, neither
peptide aggregated in water (Fig. 2a). In PBS, the Trp
fluorescence maximum from (KW)5 dose dependently
shifted from 352 to 340 nm due to its self-aggregation
(Fig. 2b). On the other hand, the Trp fluorescence of
(KW)4 did not change, implying no self-aggregation. We
did not consider (KW)2 or (KW)3 in the self-aggregation
assays because of their short chain lengths.
We further analyzed the aggregation states using CD
spectroscopy. As shown in Fig. 2c and d, the peptides in
PBS had a negative band at 200 nm, which is characteristic
of random coil. These peptides also had a band at 225 nm
due to the Trp side chain, which was consistent with earlier
reports (Liu et al. 2007; Woody 1994; Ladokhin et al.
1997). Because (KW)5 assumes a random coil conforma-
tion, it failed to form a folded conformation at concentra-
tions of 25 and 50 lM. At higher concentrations (100 and
150 lM), however, the negative band of (KW)5 was shifted
to a slightly longer wavelength, suggesting that a small
fraction of the peptide adopted a folded conformation or
was weakly aggregated (Fig. 2d). In contrast, (KW)4 pep-
tide maintained its random coil conformation in PBS at all
tested concentrations (Fig. 2c).
Localization of fluorescence-labeled peptides
To determine the site targeted by (KW)4 in E. coli CCARM
1229 and S. aureus CCARM 3090, the bacteria were
treated with the peptide and observed under CLSM. As
shown in Fig. 3, the peptide bound to the surface of E. coli
and S. aureus cells (Fig. 3), confirming that these peptides
interact with the bacterial cell membrane.
Interaction of peptides with LPS
We next used dansyl PMB displacement assays to deter-
mine the binding affinity of each peptide for LPS. The
method is based on enhanced dansyl fluorescence upon the
interaction of LPS. This fluorescence is decreased when
peptides bind to LPS and displace the dansyl PMB. As
shown in Fig. 4a, all four tested peptides dose-dependently
bound to LPS, with (KW)5 exhibiting the highest affinity.
At a concentration of 20 lM, (KW)5 displaced 81 % of
dansyl PMB from LPS. By comparison, (KW)4, (KW)3 and
Fig. 1 Model structures
of (KW)n–NH2, the linear
antibacterial peptides used in
this study (n = 2, 3, 4 and 5).
The peptide is shown as cap-
sticks, with carbon atoms in
green, nitrogen atoms in blue,
and oxygen and hydrogen atoms
in red and white, respectively
(color figure online)
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(KW)2 displaced 70, 55 and 40 %, respectively, at the same
concentration. These data clearly indicate a correlation
between chain length and LPS binding affinity.
We also used the peptides’ CD spectra to predict their
interactions with LPS. When the peptides were studied at
50 lM in a 0.1 % LPS suspension, (KW)2 and (KW)3
exhibited no secondary structure, while the longer peptides
adopted folded conformations (Fig. 4b), which is indicative
of their strong binding to LPS and was highly correlated
with their displacement of dansyl PMB.
Membrane lytic and bactericidal activities
of the peptides
We examined the peptides’ capacity to disrupt the cyto-
plasmic membrane in E. coli and S. aureus. With the
exception of (KW)2, the peptides dissipated the membrane
potential of intact E. coli CCARM 1229 (Fig. 5a) and
S. aureus CCARM 3090 (Fig. 5b) in a dose-dependent
manner, and the longer peptides were more effective than
the shorter ones. Moreover, the capacity of (KW)4 and
(KW)5 to disrupt the cytoplasmic membrane correlated
well with their antibacterial activities against the same
bacteria (Table 1). Inactive (KW)2 did not depolarize the
membrane, while (KW)3 elicited less depolarization than
the longer peptides.
The ability of the (KW)n peptides to permeabilize the
cell membrane was determined based on the uptake of
SYTOX Green, a fluorescent dye, by E. coli and S. aureus
cells. After the addition of 12.5 lM peptide in PBS, influx
of SYTOX Green fluorescence was measured for 60 min.
Treatment with (KW)4 or (KW)5 efficiently activated
uptake of the dye within 35 min in both E. coli (Fig. 5c)
and S. aureus (Fig. 5d). (KW)5 induced internalization of
Fig. 2 Structure and
organization of (KW)4 and
(KW)5 in aqueous solution.
Aggregation states of the
peptides in aqueous solution
were determined based on Trp
fluorescence and are shown as
functions of the peptide
concentration. The wavelength
at the emission maximum was
taken for plotting. (KW)4 (filled
circles), (KW)5 (filled
triangles): water (a) and PBS
(pH 7.2) (b). Concentration-
dependent CD spectroscopy was
used to examine the
conformations of the soluble
and aggregation states of the
peptides. Concentration-
dependent CD spectra for
(KW)4 (c) and (KW)5 (d) in
PBS (pH 7.2): 25 lM (solid
line), 50 lM (dashed line),
100 lM (dotted line) and
150 lM (dashed-dotted line)
Fig. 3 Confocal laser-scanning micrographs images of E. coli
CCARM 1229 (a) and S. aureus CCARM 3090 (b) cells treated with
TAMRA-labeled-(KW)4. The cells were treated with 12.5 lM
TAMRA-(KW)4 for 10 min at 37 C in PBS (pH 7.2). From left to
right: TAMRA, differential interference contrast (DIC), merged
images
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SYTOX Green more quickly than (KW)4, which is indic-
ative of its more efficient interaction and partition within
the bacterial lipid bilayer, and is consistent with its greater
hydrophobicity. (KW)3 elicited less uptake of SYTOX
Green than (KW)4 or (KW)5. These results suggest that
active peptides exert their antibacterial activities through
induction of membrane damage.
To further investigate the bactericidal activities of (KW)4
and (KW)5, we performed a time-killing assay against E.
coli CCARM 1229 and S. aureus CCARM 3090. As shown
in Fig. 5e and f, at concentrations equal to or above the
MIC, bacterial counts significantly declined within 35 min.
(KW)5 killed bacteria more quickly than (KW)4, possibly
due to its longer chain length and/or greater hydrophobicity,
which is consistent with its faster permeabilization of the
target bacterial membrane (Fig. 5c, d).
Calcein release and turbidity assay in liposomes
We also evaluated the abilities of these peptides to cause
leakage of entrapped calcein from PE:PG (7:3, w/w) LUVs,
which mimic a bacterial membrane. At a lipid-to-peptide
molar (L/P) ratio of 2.5:1, (KW)4 released 81 % of
entrapped calcein, while (KW)5 released about 73 %.
(KW)3 exhibited moderate activity, but (KW)2 was inactive
(Fig. 6a). We also examined the leakage of entrapped
calcein from using zwitterionic liposomes composed of
PC:CH (10:1, w/w), which mimic eukaryotic membranes.
At a L/P ratio of 2.5:1, (KW)5 and (KW)4 released 80 and
30 % of entrapped calcein, respectively (Fig. 6b), while
(KW)2 and (KW)3 elicited no release of calcein from
zwitterionic vesicles. The peptides’ respective abilities to
release dye from PC:CH vesicles is therefore consistent
with their hemolytic activities (Table 1).
We then measured changes of liposome turbidity to
monitor the effects of the peptides on the size of PE:PG
(7:3, w/w) vesicles. We found that the peptides increased
the turbidity of PE:PG (7:3, w/w) vesicles, indicating an
increase in vesicle size, most likely due to vesicle lysis and
aggregation (Fig. 6c) (Domingues et al. 2009).
Characterization of the Trp environment using
fluorescence spectroscopy
To characterize the Trp environment of the peptides, we
used fluorescence spectroscopy to examine the binding of
the peptides to lipid bilayers. Trp emission spectra was
recorded in the presence of negatively charged PE:PG (7:3,
w/w) or zwitterionic PC:CH (10:1, w/w) vesicles or in PBS
(Table 2). For all of the peptides except (KW)5, the fluo-
rescence maximum in buffer was around 353 nm, indi-
cating that the Trp residues were situated in a more
hydrophilic environment. For (KW)5, the fluorescence
spectra suggest that Trp is shifted from a polar to less polar
environment, possibly due to self-aggregation of the pep-
tide in PBS (Fig. 2).
The ability of the peptides to bind to PE:PG (7:3, w/w)
vesicles was in the order: (KW)4 [ (KW)5 [ (KW)3 [
(KW)2. In addition, (KW)4 exhibited a large blue shift,
indicating that its Trp side chains partitioned preferentially
into a more rigid, and hydrophobic environment within the
PE:PG (7:3, w/w) vesicles. Similarly, the Trp emission from
(KW)5 (342 nm) also exhibited a blue shift in the presence of
PC:CH (10:1, w/w) vesicles, indicating migration of Trp
residues to a more hydrophobic environment (Burstein et al.
1973). On the other hand, no blue shifts were detected for
(KW)2, (KW)3 or (KW)4 in the presence of the more
hydrophobic environment of PC:CH (10:1, w/w) vesicles.
Fig. 4 Binding affinities of the peptides for LPS, as measured using
dansyl PMB displacement assays and CD spectroscopy. P. aeruginosa
LPS (9 lg) was incubated with dansyl PMB (4 lM) for 5 min, after
which fluorescence was measured at an excitation wavelength of
340 nm and emission wavelength of 485 nm. Peptides were added at
different concentrations, and dansyl PMB fluorescence was measured
after 5 min (a). CD spectra for the peptides (50 lM) were measured in
the presence of 0.1 % LPS (b): (KW)2 (dashed-dotted line), (KW)3
(dotted line), (KW)4 (dashed line), and (KW)5 (solid line)
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We evaluated the ability of Trp residues to access the
lipid bilayer by measuring the Stern–Volmer quenching
constants (KSV) using soluble acrylamide as a quencher.
Free Trp residues in aqueous solution were fully quenched
by acrylamide (KSV = *9 M
-1) (Wimley et al. 1996), and
the KSV values for (KW)2, (KW)3, (KW)4 and (KW)5 in
PBS were (approximately) 15, 15, 14, and 11 M-1,
respectively (Table 2). That the KSV value for (KW)4 was
1.6 M-1 in the presence of PE:PG (7:3, w/w) vesicles,
indicates that the Trp residues of (KW)4 were more pro-
tected in PE:PG (7:3, w/w) vesicles than PC:CH (10:1,
w/w) vesicles (Table 2). This tendency correlated well with
the potent antibacterial activity of (KW)4. In contrast, the
hemolytic peptide (KW)5 had a lower KSV value, indicating
that its Trp residues were more anchored within the
hydrophobic core of the zwitterionic phospholipids, which
correlates well with the strong induction of calcein leakage
from the vesicles (Fig. 6b).
Fig. 5 Membrane-disruption and bactericidal activity. Dose–
response curves for peptide-induced membrane depolarization in
intact E. coli CCARM 1229 (a) and S. aureus CCARM 3090 (b).
Membrane depolarization was monitored as an increase in the
fluorescence of DiSC3-5 (excitation wavelength 620 nm, emission
wavelength 670 nm) after addition of various concentrations of
peptide: (KW)2 (filled diamonds), (KW)3 (filled squares), (KW)4
(filled circles), and (KW)5 (filled triangles). The increase in fluores-
cence obtained using 0.1 % Triton X-100 was taken as 100 %.
Membrane permeabilization was monitored based on entry of
SYTOX Green dye. Bacterial cells (2 9 107 CFU/ml) in PBS were
incubated with 1 lM SYTOX Green dye. Peptides were added at a
concentration of 12.5 lM, after which uptake of SYTOX Green
through the E. coli (c) or S. aureus (d) plasma membrane was
measured based on the time course of fluorescence changes at an
excitation wavelength of 485 nm and emission wavelength of
520 nm: (KW)2 (filled diamonds), (KW)3 (filled squares), (KW)4
(filled circles), (KW)5 (filled triangles), and Melittin (open circles).
Kinetics of the bactericidal activity against E. coli CCARM 1229
(e) and S. aureus CCARM 3090 (f). Bacteria treated with the
respective peptides were diluted at the appropriate times and then
plated on LB agar. CFUs were then counted after 16 h of incubation
at 37 C. Black (KW)4, white (KW)5, squares and triangles 1 and 2
times the MIC, respectively; cells (2 9 105 CFU/ml) incubated in the
absence of any peptide served as controls
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Structures of the peptides in liposomes
We determined the secondary structures of the peptides in
aqueous solution and lipid membranes. (KW)2 and (KW)3
displayed no secondary structure in aqueous solution (data
not shown) or lipid membranes. (KW)4 and (KW)5 adopted
folded conformations on liposomes (Fig. 7). (KW)5 dis-
played a positive band at 197 nm and a negative band at
210 nm on PC:CH vesicles (Fig. 7b), indicating that its
side chain partitioned preferentially into the more rigid and
hydrophobic environment of the lipid bilayer, which is
consistent with its potent hemolytic activity.
Observation of (KW)4 activity in E. coli using SEM
To examine the action of (KW)4 against E. coli CCARM
1229 in more details, we used SEM to observe the mor-
phological changes that occur upon incubation of the
peptide with bacteria. In the absence of peptide, the bac-
teria had a smooth surface (Supplementary Fig. 1A), but in
the presence of 12.5 lM peptide the treated bacteria
appeared clumped with more crenated surfaces (Supple-
mentary Fig. 1B).
Bacterial agglutination
To confirm the bacterial aggregation, we incubated E. coli,
S. aureus, or P. aeruginosa with various concentrations of
peptide for 1 h. At higher concentrations of peptide, there
was greater agglutination and bacterial clumping (Supple-
mentary Fig. 2). (KW)4 induced agglutination of all three
bacterial strains. Bacterial aggregation was not observed in
the absence of peptide. These results demonstrate the
agglutination-inducing activity of (KW)4 peptide against
both Gram-negative and Gram-positive bacteria.
Discussion
De novo design of short peptides is an alternative strategy
for the development of AMPs that are selective for bacte-
ria, with little or no effect on human cells. We designed
peptides comprised of alternating Lys and Trp residues,
which we previously showed to have antimicrobial activity
(Gopal et al. 2011). When choosing a cationic amino acid
for the present study, we chose Lys over Arg because, the
guanidinium group in the side chain of Arg is active in both
Fig. 6 Peptide actions on lipid bilayers. Percent leakage of calcein
from PE:PG (7:3, w/w) (a) and PC:CH (10:1, w/w) vesicles (b) at pH
7.4 was measured for 25 min after the addition of various doses of
peptide. c LUV aggregation. Solutions containing various concentra-
tions of peptide were added to a suspension of 400 lM PE:PG (7:3,
w/w) LUVs, after which aggregation was monitored based on changes
in the absorbance of the LUVs at 405 nm: (KW)2 (filled diamonds),
(KW)3 (filled squares), (KW)4 (filled circles), and (KW)5 (filled
triangles)
Table 2 Tryptophan emission maxima of 2 lM peptides and KSV in PBS (pH 7.2) or in the presence of 200 lM PE:PG (7:3, w/w) SUVs and
200 lM PC:CH (10:1, w/w) SUVs
Peptides kmax buffer (nm) Blue shift (nm) KSV (M
-1)a
PE:PG (7:3, w/w) PC:CH (10:1, w/w) Buffer PE:PG (7:3, w/w) PC:CH (10:1, w/w)
(KW)2 353 8 2 15 2.8 5.8
(KW)3 353 11 2 15 2.3 5.3
(KW)4 353 17 5 14 1.6 5.1
(KW)5 351 14 9 11 2.0 4.3
a KSV is the Stern–Volmer constant. KSV (M
-1) were determined from the Stern–Volmer equation F0/F1 = 1 ? KSV (Q), where Q is the
concentration of quencher (acrylamide). Concentration of the quencher varied from 0.04 to 0.20 M
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microbial and mammalian cell membranes (Yang et al.
2003). Lys also possesses one positive charge but lacks a
guanidinium group, making it less toxic to mammalian
cells (Andra et al. 2007). In addition, the cost of producing
Arg-containing peptides is higher than that of producing
Lys-containing ones, which is an important factor when
considering drug design and development. Finally, Trp was
selected, based on reports indicating that AMPs containing
Trp are more active than those containing either Tyr or Phe
(Dathe et al. 2004; Strom et al. 2003; Subbalakshmi et al.
2000). One explanation could be that the bulkier side chain
of Trp may interact more strongly with the hydrophobic
membrane core than other non-polar amino acids, such as
Phe and Tyr (Strom et al. 2002; Wimley and White 1996).
The results obtained in earlier studies of the effect of
chain length on the activity of AMPs have varied. In one
study of a (RW)n series, chain length correlated well with
antibacterial and hemolytic activities (Liu et al. 2007). But
in another study of H-(LARL)3-(LRAL)n peptides,
increasing chain length reduced the antibacterial activity
while increasing hemolysis (Niidome et al. 2005). In the
present study, we observed that antibacterial activity
improved with increasing chain length up to (KW)4; there
was no further increase in antibacterial activity when the
chain length exceeded eight amino acids. The order of the
activity was (KW)2 \ (KW)3 \ (KW)4 [ (KW)5. (KW)5
exhibited nearly the same antibacterial activity as (KW)4,
except when treating S. typhimurium and P. aeruginosa in
PBS. The observed increase in antibacterial activity as the
peptide chain lengthened is attributable to increases in the
cationicity, hydrophobicity and clustering of the KW motifs
(Fig. 1). When chain length exceeded the optimum eight
residues, as with (KW)5, antibacterial activity declined, and
there was a greater propensity for aggregation in aqueous
buffer due to the increased hydrophobicity. The observed
difference in the peptides’ ability to aggregate in PBS and
SP buffer may be attributable to differences in the ionic
strengths of the two buffers. Our results suggest that (KW)5
was soluble and weakly self-aggregated in PBS (Fig. 2).
The hemolytic activities of the (KW)n peptides
increased with chain length. Short peptides were inactive,
and (KW)4 showed modest hemolytic activity at high
concentrations. (KW)5 exhibited marked hemolytic activ-
ity, reflecting an increase in hydrophobicity as well as the
peptide’s ability to weakly aggregate. Several studies have
suggested that AMPs in a self-aggregated state in aqueous
solution, where there is an increase in hydrophobic inter-
actions, mediate hemolytic activity (Feder et al. 2000;
Javadpour and Barkley 1997). Our results with (KW)5 are
consistent with that idea. Only (KW)4 exhibited good
antibacterial activity without a high degree of hemolysis.
This may reflect an optimal balance of cationicity and
hydrophobicity, which are features needed for broad-
spectrum antibacterial activity without hemolysis
(Javadpour et al. 1996; Fernandez-Lopez et al. 2001).
AMPs kill bacteria either through permeabilization of the
cytoplasmic membrane or by binding with intracellular
targets like nucleic acids (Brogden 2005). Our CLSM
results indicate that (KW)n peptides interact with the bac-
terial surface (Fig. 3), suggesting (KW)n act by damaging
the cytoplasmic membrane, rather than binding to nucleic
acids. Gram-negative bacteria have two-cell membranes,
the outer membrane and inner cytoplasmic membrane. The
outer leaflet of the outer membrane consists of LPS, making
it necessary for the peptide to bind to LPS and cross the
outer membrane before entering the periplasmic space
(Farnaud et al. 2004; Bhattachariya and Ramamoorthy
2009). For this reason, we examined the peptides’ ability to
bind LPS. We found that longer peptides strongly bound
LPS (Fig. 4) and induced membrane depolarization
(Fig. 5a, b). The higher affinities of (KW)4 and (KW)5 for
LPS correlated with their abilities to induce membrane
depolarization, suggesting they effectively disrupted the
outer membrane and accessed the cytoplasmic membrane.
The peptides then appeared to damage the inner membrane
(Fig. 5c, d) to exert their bactericidal action (Fig. 5e, f).
Using lipid bilayers, it was previously shown that the
mechanism of action of AMPs involves two stages: initial
Fig. 7 CD spectra for (KW)2
(dashed-dotted line), (KW)3
(dotted line), (KW)4 (dashed
line), and (KW)5 (solid line) in
the presence of PE:PG (7:3,
w/w) (a) and PC:CH (10:1,
w/w) vesicles (b)
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electrostatic interaction of the cationic residues (Lys or
Arg) of the peptides with the anionic lipids of the bacterial
membrane (Juffer et al. 2001; Shepherd et al. 2001), fol-
lowed by hydrophobic interaction of aromatic side chain-
containing amino acids with the lipid bilayer (Schibli et al.
2002; Wimley and White 1996). Our results are consistent
with that mechanism. The observed Trp blue shifts and KSV
values (Table 2) indicate that for all of the (KW)n peptides
tested, the Trp residues partitioned into the lipid bilayer of
PE:PG (7:3, w/w) vesicles. The smallest peptide of the
series, (KW)2, induced no calcein leakage or aggregation
(Fig. 6), which likely reflects this peptide’s inability to
permeate the bacterial membrane. (KW)3 exhibited a
greater ability to bind LPS and induce membrane perme-
abilization, calcein leakage and aggregation than (KW)2,
but its effects were still considerably weaker than those of
(KW)4 and (KW)5. Furthermore, (KW)2 and (KW)3 lacked
definite secondary structure on lipid membranes, as evi-
denced by their CD spectra. Briefly, the CD spectra showed
that at a P/L ratio of 1:50, (KW)4 and (KW)5 formed stable
structures within the negatively charged lipid membrane,
suggesting interfacial association of the peptides (Fig. 7).
Clearly, peptide length, hydrophobicity and charged/
hydrophobic surface ratio correlate with the degree of
membrane disruption/permeabilization. The exception is
(KW)5, which showed less antibacterial activity than
(KW)4, though its chain length is longer. This may reflect
the weak aggregation of (KW)5 in aqueous solution, which
would reduce its electrostatic potential and therefore its
antibacterial activity. Our Trp blue shift assays and
quenching experiments showed that its aggregation state
led (KW)5 to bind more weakly to membranes than did
(KW)4, which would also reduce its ability to permeabilize
the membrane. Consistent with this interpretation, the
degree of membrane disruption is reportedly dependent on
the concentration of peptide adsorbed onto the negatively
charged lipid membrane (Ringstad et al. 2007).
Many Trp-rich AMPs are not cell type-selective (Sub-
balakshmi et al. 1996; Ahmad et al. 1995; Schibli et al.
2002). In the present study, only (KW)5 caused significant
leakage from PC:CH liposomes, and only (KW)5 exhibited
a large blue shift, which indicates that only (KW)5 entered
the hydrophobic core of the mammalian membrane. Our
results also show that (KW)n peptides bind more tightly to
bacterial membrane-mimicking liposomes than to those
mimicking a mammalian membrane. This is because bac-
terial membranes consist of almost 25 % anionic lipids,
whereas mammalian membranes contain large amounts of
PC lipids, with negligible amounts of anionic lipids
(Verkleij et al. 1973). Anionic lipids promote the initial
electrostatic interaction between positively charged AMPs
and the negatively charged membrane. Because the mam-
malian membrane is deficient in anionic lipids, AMPs
cannot undergo a proper initial interaction. Infact, the
positive charge of PC lipids may actually repulse the basic
residues of AMPs. These results are consistent with an
earlier study (Liu et al. 2007), which confirmed that (RW)n
peptides strongly interact with PG-containing bilayers, but
possess only moderate affinity toward mammalian model
membranes. However, it is the hydrophobic interaction
between AMPs and the lipid bilayer core that is essential
for membrane disruption. Consequently, it is the more
hydrophobic AMPs that lack cell type selectivity and cause
more damage to membranes (Tossi et al. 2000; Makovitzki
et al. 2006). Similarly, highly aggregated peptides having
high hydrophobicity reportedly induce fatal damage to
mammalian membranes (Biggs et al. 2007). The hemolysis
and evoked calcein release seen with (KW)5 are consistent
with that finding.
In addition to causing membrane damage, (KW)4 also
elicited bacterial agglutination. Liposome agglutination is
dependent on the number of electrostatic/hydrophobic
interactions with the peptides, which in turn depends on the
number of Lys/Trp residues (Stromstedt et al. 2009). Our
data show that several Lys and Trp residues are required
for permeabilization of the bacterial membrane and
agglutination of model liposomes. Acrylamide quenching
studies corroborate those results, as longer peptides per-
meated deeper into the lipid bilayer core than shorter ones
(Table 2). The formation of macroscopic aggregates
involves at least two steps: peptide-membrane association
with concomitant charge neutralization followed by vesicle
association (Cummings and Vanderlick 2007; Fujii et al.
1993). In addition to altering surface charge density upon
adsorption to the membrane, peptides dehydrate lipid head
groups and induce aggregation of phospholipid vesicles.
Reducing charge density also reduces peptide–peptide
long-distance repulsion, which facilitates the formation of
hydrophobic interactions between peptides associated with
adjacent bilayers (De Meulenaer et al. 1997). Other studies
found that more highly charged residues, and neutralization
of those charges may be required to induce fusion between
giant liposomes (Nomura et al. 2004). It has also been
reported that membrane destabilization is essential for
fusion (Ryan et al. 2005 and Domingues et al. 2009), and
that peptides and proteins forming hydrophobic or hydro-
philic cationic clusters show membrane-fusion activity
(Cummings and Vanderlick 2007; Niidome et al. 2000;
Fujii et al. 1993; Abu-Ghazaleh et al. 1992). In the present
study, (KW)4 and (KW)5 damaged membranes and caused
vesicles aggregation/fusion (Fig. 6). Because (KW)n pep-
tides contain only Lys and Trp residues, they can engage in
both electrostatic and hydrophobic interactions with anio-
nic lipid membranes and induce membrane destabilization
and agglutination when dispersed on negatively charged
vesicles.
Effect of repetitive lysine–tryptophan motifs 657
123
The ability to cause vesicle leakage and aggregation was
first identified with seminal ribonuclease (Mancheno et al.
1994) and various other synthetic peptides (Stromstedt
et al. 2009), including K7, R7, K7W7 and R7W7. In the
present study, (KW)4 destroyed the E. coli membrane
(Supplementary Fig. 1) and caused agglutination of the
bacterial cells (Supplementary Fig. 2). In addition to cell–
cell aggregation, an extracellular matrix-like material was
observed within the cell agglomeration. Proteins or pep-
tides do not induce spontaneous aggregation of bacterial
cells (Jung et al. 2009). Instead, agglutination results from
peptide–charge and peptide–lipid interactions, which most
likely involves hydrophilic/hydrophobic interactions with
bacterial membranes (Gorr et al. 2008). Our finding that
LPS-deficient Gram-positive bacteria, as well as liposomes,
showed agglutination upon peptide treatment suggests that
LPS does not play a role in bacterial agglutination.
Other studies have shown that RNase 3 triggers vesicle
aggregation followed by membrane disruption, whereas
RNase 7 induces dye leakage before aggregation (Torrent
et al. 2009). Our SYTOX Green assays showed that (KW)4
and (KW)5 caused membrane destabilization at their MIC.
In addition, the membrane depolarization assays showed
that the peptides induced outer membrane permeabilization
at concentrations lower than the MIC, and the time-frame
of the effects of (KW)4 and (KW)5 on membrane perme-
ability was consistent with the peptides’ bactericidal
activities. However, (KW)4 induced bacterial agglutination
at significantly higher concentrations than were needed to
cause membrane permeabilization and bactericidal activity.
This suggests that cell aggregation occurs after bacterial
killing, and the initial step in the mechanism involves
membrane disruption. Consistent with that idea, it is widely
believed that membrane disruption is the primary mecha-
nism by which AMPs exert their bactericidal effects
(Hancock 2001; Brogden 2005; Tossi et al. 2000; Shai
2002). Induction of agglutination would help to clump
bacterial cells together, which would increase their sus-
ceptibility to phagocytosis (Gorr et al. 2008). The ability of
(KW)4 to bind to the bacterial membrane and induce
agglutination makes it a potential candidate for future
optimization.
In conclusion, the steps of the proposed mechanism by
which (KW)n peptides exert their bactericidal effects are as
follows (Fig. 8): (1) The peptide binds to membrane
phospholipid polar heads through electrostatic interactions.
(2) The hydrophobic residues promote peptide–lipid
interactions, the clustering of cell/liposomes–peptide
complexes and destabilization of the lipid bilayer. (3) Cell/
liposome aggregation. Membranolytic peptides with
agglutinating properties may eventually represent as a new
class of short antibacterial peptides useful for killing bac-
teria resistant to other types of antibiotics.
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